Navigation path

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece


   Infocentre

Published: 22 March 2016  
Related category(ies):
Health & life sciences  |  Special Collections  |  Research policy

 

Countries involved in the project described in the article:
Austria  |  Czech Republic  |  Germany  |  Italy  |  Netherlands  |  Norway  |  Sweden  |  United Kingdom
Add to PDF "basket"

Cancer test would pinpoint high-risk women

An EU-funded project is developing a single genetic test that would indicate an individual woman's risk of developing breast, cervical, womb or ovarian cancer - potentially saving lives.

Picture of girl pink ribbon

© kolinko_tanya - fotolia.com

The proposed test, being developed by the FORECEE project, would enable women at high risk to take preventative actions earlier, or to halt progression of incipient cancer before it becomes invasive. The test would also spare women with a low risk of developing these cancers from unnecessary screening tests.

Breast, cervical, womb, and ovarian cancers account for 47% of all cancers in women, with some 516 000 new cases diagnosed in the EU every year.

FORECEE’s test would screen for molecular changes in cervical cells that indicate a woman’s individual risk of developing these cancers. Project researchers say women would not need to go for extra appointments to take advantage of the test: cervical cells are currently collected during screening for cervical cancer.

As part of their work, the researchers are also examining the legal, social, ethical and behavioural issues related to the implementation of the risk prediction test. They are also developing ways of communicating the complex medical information extracted from the tests.

“It’s important to provide the women concerned with clear and easily understandable information that spells out the pros and cons of taking the test or not,” says Odette Wegwarth, project leader and senior research scientist at the Harding Center for Risk Literacy. “Only then can they really evaluate its potential benefits and harms and make an informed decision.”

Project details

  • Project acronym: FORECEE
  • Participants: UK (Coordinator), Sweden, Czech Republic, Norway, Italy, Germany, Netherlands, Austria
  • FP7 Proj. N° 634570
  • Total costs: € 7 994 746
  • EU contribution: € 7 994 746
  • Duration: Spetember 2015 - August 2019

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project website
Project information on CORDIS






  Top   Research Information Center
 
Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Finland
  France
  Gambia
  Georgia
  Germany
  Ghana
  Greece